A Study of Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy
Clinical trial NCT03015623 · UNKNOWN
Trial details
- NCT number
- NCT03015623
- Sponsor
- Sentien Biotechnologies, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-20
- Primary completion
- 2021-12-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.